<DOC>
	<DOCNO>NCT00656604</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , dynamic contrast-enhanced magnetic resonance imaging ( DCE-MRI ) , magnetic resonance spectroscopy ( MRS ) , tissue proteomics , may help doctor find diagnose breast cancer plan best treatment . PURPOSE : This clinical trial study MRI MRS without tissue proteomics analysis see well work evaluate healthy woman woman undergo surgery breast cancer .</brief_summary>
	<brief_title>Evaluation Patients With Breast Cancer Using DCE-MRI , MRS , Proteomics</brief_title>
	<detailed_description>OBJECTIVES : - To correlate data obtain DCE-MRI MRS healthy woman woman undergo surgery breast cancer data obtain conventional X-ray mammography , tissue proteomics , histopathology . - To evaluate impact MRSI data treatment planning radiotherapy and/or surgery . OUTLINE : Healthy participant undergo dynamic contrast-enhanced ( DCE ) -MRI magnetic resonance spectroscopic ( MRS ) longitudinal study breast image spectroscopy . Patients breast cancer undergo DCE-MRI MRS prior initiation treatment ( i.e. , surgery , chemotherapy , radiotherapy ) . After treatment begin , patient undergo repeat imaging ( 1 per month ) follow-up assessment longitudinal study . Breast tissue sample collect patient undergo surgery . Samples evaluate histopathological proteomic analysis correlation DCE-MRI MRS finding . The study intervention discontinue definitive surgery perform . PROJECTED ACCRUAL : A total 10 healthy participant 40 patient breast cancer accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Women breast tumor plan undergo surgical resection Healthy volunteer , include constitutionally healthy female history breast cancer Hormone receptor status specify PATIENT CHARACTERISTICS : Female Menopausal status specify Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Not acutely ill No nonmagnetic resonancecompatible ferromagnetic material present body PRIOR CONCURRENT THERAPY : Prior chemotherapy and/or radiotherapy allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
</DOC>